Alopecia Treatment Market Size, Strategic Analysis, Growth Drivers, Industry Trends, Demand and Future Opportunities and Forecast Period
The alopecia treatment market was
valued at around USD 9.9 billion in 2023 and is expected to grow to USD 26.7
billion in 2034, with a CAGR of 9.5% from 2024 to 2034. Alopecia treatments are
critical for restoring hair growth and boosting people's overall health. The
market is aligned with the healthcare industry, making it both sustainable and
increasing.
Alopecia, often known as hair loss, is a condition that
affects millions of people throughout the world, including men and women of all
ages. The disorder can take several forms, including androgenic alopecia
(pattern baldness) and alopecia areata (patchy hair). Alopecia treatment
includes a wide range of medicinal, surgical, and cosmetic methods aimed at
addressing hair loss.
Request
For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/alopecia-treatment-market
GROWTH DRIVERS
The number of people affected by various types of alopecia,
such as androgenetic alopecia and alopecia areata, is on the increase.
According to the American Hair Loss Association, androgenetic alopecia, also
known as common male pattern baldness (MPB), accounts for more than 95% of hair
loss in men. By the age of 35, two-thirds of American men will see notable hair
loss, and by the age of 50, nearly 85% will have noticeably thinning hair.
Advancements in treatment alternatives, such as laser
therapy, PRP therapy, and stem cell therapy, are driving market expansion.
These advances in treatment approaches give patients with effective and
numerous options, hence driving market growth. The increase in healthcare cost
allows more people to purchase more modern alopecia treatments,
hence driving market growth.
According to Statista, the global beauty and personal care
market is expected to earn USD 646.2 billion in revenue by 2024. Personal care
is the market's largest category, with a market volume of USD 282.8 billion
projected for 2024. The growing senior population, which is more prone to
alopecia, increases the demand for treatment options, adding to market growth.
MARKET
SEGMENTATION:
· By
Disease Type-
·
Androgenic
Alopecia
·
Alopecia
Areata
·
Alopecia
Totalis and Others
· By
Gender-
·
Male
·
Female
· Route
of Administration-
·
Topical
o
Creams
o
Oils
o
Gels
o
Shampoo
o
Lotion
·
Injectable
o
Platelet
Rich Plasma
o
Steroid
Injections
o
Injectable
Filler
·
Oral
·
Hair
Transplant Services
·
Low-Level
Laser Therapy
· By
End User-
o
Hospitals
o
Dermatologic
and Trichology Clinics
o
Home
care settings
o
Aesthetic
Clinics
· By
Region-
o
North
America
o
Europe
o
Asia
Pacific
o
The
Middle East and Africa
o
South
America
Global Key
Players:
· Elli
Lilly and Company
· Teva
Pharmaceutical Industries Ltd.
· Merck
& Co., Inc.
· Johnson
& Johnson, Inc.
· Dr.
Reddy’s Laboratories Ltd.
· Cipla
Ltd.
· Cellmid
Ltd.
· Taisho
Pharmaceutical Holdings Co., Ltd
· Shiseido
Co., Ltd.
· Zhangguang
101 Science & Technology Co., Ltd.
· Pfizer
· Thera
dome
· LUTRONIC
· Curallux
· Other
Players
For
More Information about this Report @ https://www.xresearch.biz/shop/alopecia-treatment-market
About
Us: -
xResearch is a
market research and consulting organization that uses unique data, expert
analysis, and new technologies to create trusted intelligence on industries.
Our research is focused on delivering an informed and impartial view on
essential market data of industry, and it is primarily driven by an in-depth
study covering the following parameters: Market Sizing and Forecasting, Market
Segmentation, Competitive Analysis, Strategic Assessment and Business
Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-619-8140
Comments
Post a Comment